AcelRx Pharmaceuticals Inc. (ACRX)

2.69
NASDAQ : Health Technology
Prev Close 2.72
Day Low/High 2.63 / 2.75
52 Wk Low/High 1.99 / 5.05
Avg Volume 1.58M
Exchange NASDAQ
Shares Outstanding 78.91M
Market Cap 214.65M
EPS -0.80
P/E Ratio N/A
Div & Yield N.A. (N.A)

Stocks Under $10 Weekly Summary

We rang the register on part of a high-flying position and added to another on weakness.

Stocks Under $10 Weekly Summary

With the small-cap heavy Russell 2000 leading the major market index pack last week, we saw a number of pronounced moves higher in the portfolio.

Stocks Under $10 Weekly Summary

Another melt-up for the stock market, together with a late-Friday surge was a positive for several portfolio holdings.

Stocks Under $10 Weekly Summary

We closed our position in Fitbit for a healthy profit and added twice to USA Technologies last week.

Stocks Under $10 Weekly Summary

We booked hefty wins last week exiting Blue Apron and GE and trimming our position in Fitbit.

Stocks Under $10 Weekly Summary

While the overall stock market finished last week essentially unchanged, the portfolio had several outperformers.

First Week Of September 20th Options Trading For AcelRx Pharmaceuticals (ACRX)

First Week Of September 20th Options Trading For AcelRx Pharmaceuticals (ACRX)

Investors in AcelRx Pharmaceuticals Inc saw new options become available this week, for the September 20th expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 238 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Stocks Under $10 Weekly Summary

We added one new position and doubled down on another during a very good week for the portfolio.

Stocks Under $10 Weekly Summary

We exited two positions last week as the portfolio and the market started off the year in the green.

Interesting ACRX Put Options For February 15th

Interesting ACRX Put Options For February 15th

Investors in AcelRx Pharmaceuticals Inc saw new options become available this week, for the February 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ACRX options chain for the new February 15th contracts and identified the following put contract of particular interest.

Adding to This Specialty Pharmaceutical Firm

AcelRx Pharma has really taken it on the chin of late.

Stocks Under $10 Weekly Summary

We initiated two new portfolio positions last week.

Stocks Under $10 Weekly Summary

Despite steep declines in the broader market last week, the portfolio had several winners and was helped by our large cash position.

Stocks Under $10 Weekly Summary

We added to two positions last week, as positive action in the market led the Russell 2000 to climb.

Stocks Under $10 Weekly Summary

Given the market pressures of last week, there was little room to hide as the gut punches continued to hit small-cap and technology stocks.

Stocks Under $10 Weekly Summary

We added to several positions on weakness last week.

Stocks Under $10 Weekly Summary

Despite swimming against the recent tide with small-cap stocks, we have several positions that are more than holding their own.

Portfolio Name's Stock Offering Is Dilutive

We are not adding to our AcelRx position on this weakness, despite believing in the underlying story, until we have more information.

Election Impact on the Portfolio

While health care holdings may suffer, cannabis-related holdings should get a boost.

Stocks Under $10 Weekly Summary

We saw a number of our positions rebound along with the market last week.

Stocks Under $10 Weekly Summary

We re-initiated a position during a volatile week in the market.

Sailing Stormy Seas, Plus Updates on 3 Positions

Here’s when we would consider adding to Aurora Cannabis.

First Week Of June 2019 Options Trading For AcelRx Pharmaceuticals (ACRX)

First Week Of June 2019 Options Trading For AcelRx Pharmaceuticals (ACRX)

Investors in AcelRx Pharmaceuticals Inc saw new options become available this week, for the June 2019 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 239 days until expiration the newly available contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Stocks Under $10 Weekly Summary

Amid volatile market activity, we added to four positions last week.

Adding to the Portfolio’s ‘Wild Child’

We are buying more shares of AcelRx Pharmaceuticals following an FDA advisory committee’s approval of its NDA candidate.

Stocks Under $10 Weekly Summary

The majority of our positions outperformed our benchmark during a challenging week for the stock market.

Insiders Seeing Green With ACRX At New 52-Week High

Insiders Seeing Green With ACRX At New 52-Week High

In trading on Monday, shares of AcelRx Pharmaceuticals Inc touched a new 52-week high of $5.03/share. That's a 224.52% rise, or $3.48 per share from the 52-week low of $1.55 set back on 10/19/2017.

It’s a Key Day for This Specialty Pharma Position

FDA review of AcelRx Pharma's DSUVIA should produce a significant reaction in the shares.

TheStreet Quant Rating: D- (Sell)